GlassScriptPhysician profile
Arthur Michael Dizon
NPI 1609195304
$6,009.27
in general payments reported to CMS, 2019-2025
17 companies · $6.26 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,149 · 2021: $29.76 · 2022: $3,129 · 2023: $1,141 · 2024: $555 · 2025: $6.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,090 · Food and Beverage: $603 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,090.00 |
| Food and Beverage | $603.05 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,450.08 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $624.18 | 2019-2022 | |
| Covidien LP | $400.00 | 2019 | |
| Astellas Pharma US INC | $138.43 | 2024 | Veozah |
| Teleflex LLC | $87.67 | 2019 | |
| Gynesonics, INC. | $61.34 | 2022 | |
| Abbvie INC. | $38.67 | 2019 | |
| Sumitomo Pharma America, INC. | $36.73 | 2023-2024 | Myfembree, Gemtesa |
| Olympus America INC. | $30.57 | 2023 | Olympus |
| Channel Medsystems, INC. | $26.96 | 2023 | |
| Axonics, INC. | $18.63 | 2024 | Bulkamid, Axonics |
| Mylan Pharmaceuticals INC. | $17.42 | 2019 | |
| Hologic Sales and Service, LLC | $17.25 | 2023 | Acessa Provu System |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Pfizer INC. | $15.97 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $15.61 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Dizon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.